The H1-receptor antagonist cetirizine ameliorates high-fat diet-induced glucose intolerance in male C57BL/6 mice, but not diabetes outcome in female non-obese diabetic (NOD) mice. (March 2014)
- Record Type:
- Journal Article
- Title:
- The H1-receptor antagonist cetirizine ameliorates high-fat diet-induced glucose intolerance in male C57BL/6 mice, but not diabetes outcome in female non-obese diabetic (NOD) mice. (March 2014)
- Main Title:
- The H1-receptor antagonist cetirizine ameliorates high-fat diet-induced glucose intolerance in male C57BL/6 mice, but not diabetes outcome in female non-obese diabetic (NOD) mice
- Authors:
- Anvari, Ebrahim
Wang, Xuan
Sandler, Stellan
Welsh, Nils - Abstract:
- <abstract> <title>Abstract</title> <p> <italic> <bold>Background.</bold> </italic> It has been proposed that the histamine 1-receptor (H1-receptor) not only promotes allergic reactions, but also modulates innate immunity and autoimmune reactions. In line with this, we have recently reported that the H1-receptor antagonist cetirizine partially counteracts cytokine-induced beta-cell signaling and destruction. Therefore, the aim of this study was to determine whether cetirizine affects diabetes in NOD mice, a model for human type 1 diabetes, and glucose intolerance in high-fat diet C57BL/6 mice, a model for human glucose intolerance.</p> <p> <italic> <bold>Methods.</bold> </italic> Female NOD mice were treated with cetirizine in the drinking water (25 mg/kg body weight) from 9 until 30 weeks of age during which precipitation of diabetes was followed. Male C57BL/6 mice were given a high-fat diet from 5 weeks of age. When the mice were 12 weeks of age cetirizine was given for 2 weeks in the drinking water. The effects of cetirizine were analyzed by blood glucose determinations, glucose tolerance tests, and insulin sensitivity tests.</p> <p> <italic> <bold>Results.</bold> </italic> Cetirizine did not affect diabetes development in NOD mice. On the other hand, cetirizine treatment for 1 week protected against high-fat diet-induced hyperglycemia. The glucose tolerance after 2 weeks of cetirizine treatment was improved in high-fat diet mice. We observed no effect of cetirizine on the<abstract> <title>Abstract</title> <p> <italic> <bold>Background.</bold> </italic> It has been proposed that the histamine 1-receptor (H1-receptor) not only promotes allergic reactions, but also modulates innate immunity and autoimmune reactions. In line with this, we have recently reported that the H1-receptor antagonist cetirizine partially counteracts cytokine-induced beta-cell signaling and destruction. Therefore, the aim of this study was to determine whether cetirizine affects diabetes in NOD mice, a model for human type 1 diabetes, and glucose intolerance in high-fat diet C57BL/6 mice, a model for human glucose intolerance.</p> <p> <italic> <bold>Methods.</bold> </italic> Female NOD mice were treated with cetirizine in the drinking water (25 mg/kg body weight) from 9 until 30 weeks of age during which precipitation of diabetes was followed. Male C57BL/6 mice were given a high-fat diet from 5 weeks of age. When the mice were 12 weeks of age cetirizine was given for 2 weeks in the drinking water. The effects of cetirizine were analyzed by blood glucose determinations, glucose tolerance tests, and insulin sensitivity tests.</p> <p> <italic> <bold>Results.</bold> </italic> Cetirizine did not affect diabetes development in NOD mice. On the other hand, cetirizine treatment for 1 week protected against high-fat diet-induced hyperglycemia. The glucose tolerance after 2 weeks of cetirizine treatment was improved in high-fat diet mice. We observed no effect of cetirizine on the insulin sensitivity of high-fat diet mice.</p> <p> <italic> <bold>Conclusion.</bold> </italic> Our results suggest a protective effect of cetirizine against high-fat diet-induced beta-cell dysfunction, but not against autoimmune beta-cell destruction.</p> </abstract> … (more)
- Is Part Of:
- Upsala journal of medical sciences. Volume 120:Number 1(2015:Mar.)
- Journal:
- Upsala journal of medical sciences
- Issue:
- Volume 120:Number 1(2015:Mar.)
- Issue Display:
- Volume 120, Issue 1 (2015)
- Year:
- 2015
- Volume:
- 120
- Issue:
- 1
- Issue Sort Value:
- 2015-0120-0001-0000
- Page Start:
- 40
- Page End:
- 46
- Publication Date:
- 2014-03
- Subjects:
- Medicine -- Periodicals
Medicine -- Periodicals
Electronic journals
610.5 - Journal URLs:
- http://informahealthcare.com/loi/ups ↗
http://informahealthcare.com/ups ↗
http://search.epnet.com/direct.asp?db=aph&jn="BE3"&scope=site ↗
https://ujms.net/index.php/ujms/issue/view/523 ↗
http://informahealthcare.com ↗
http://www.tandf.co.uk/journals/titles/03009734.html ↗ - DOI:
- 10.3109/03009734.2014.967422 ↗
- Languages:
- English
- ISSNs:
- 0300-9734
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9122.700000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3290.xml